Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.
about
Glucose-6-phosphate dehydrogenase and NADPH redox regulates cardiac myocyte L-type calcium channel activity and myocardial contractile functionImpact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.Mechanism of glucose-6-phosphate dehydrogenase-mediated regulation of coronary artery contractility.Glc-6-PD and PKG contribute to hypoxia-induced decrease in smooth muscle cell contractile phenotype proteins in pulmonary artery.Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.Protein Expression by Human Pulmonary Artery Smooth Muscle Cells Containing a BMPR2 Mutation and the Action of ET-1 as Determined by Proteomic Mass Spectrometry.A Metabolic Shift toward Pentose Phosphate Pathway Is Necessary for Amyloid Fibril- and Phorbol 12-Myristate 13-Acetate-induced Neutrophil Extracellular Trap (NET) FormationVascular smooth muscle cell contractile protein expression is increased through protein kinase G-dependent and -independent pathways by glucose-6-phosphate dehydrogenase inhibition and deficiencyPerturbation of human coronary artery endothelial cell redox state and NADPH generation by methylglyoxal.Dehydroepiandrosterone promotes pulmonary artery relaxation by NADPH oxidation-elicited subunit dimerization of protein kinase G 1α.The effect of melaxen on the activity of caspases and the glutathione antioxidant system in toxic liver injury.Classification of Plasmodium falciparum glucose-6-phosphate dehydrogenase inhibitors by support vector machine.Glucose-6-phosphate dehydrogenase plays a critical role in hypoxia-induced CD133+ progenitor cells self-renewal and stimulates their accumulation in the lungs of pulmonary hypertensive rats.Stress-induced GSK3 regulates the redox stress response by phosphorylating glucose-6-phosphate dehydrogenase in Arabidopsis.Subclinical reduced G6PD activity in rheumatoid arthritis and Sjögren's Syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome.
P2860
Q28580561-D0F52A31-BE18-42A9-A950-2B3FA91BCDFDQ34317717-12A92051-DCFF-49B4-B5AD-8FAFB9473AB6Q35056954-DC1E9E83-8CC2-40E9-8344-DC525695E5D8Q36185490-6E1E496A-8D11-4A04-BCCE-E4E7F6BF590FQ38668387-522E2352-D201-429F-8333-BD8A7F5D2211Q39313701-39924FE0-B240-4CCA-97FC-49DAEBC07F60Q40710845-0C7ECCE9-548F-4CF8-A7BC-F9AB66198C30Q41630666-CDCA2153-DC60-4049-8496-45D565093DC4Q41883018-8795FE79-9858-43CA-BEBC-C1616B923145Q41943788-B2C4C918-4974-471B-AB1E-7F81F9FD0DECQ42002519-A6D28EDF-63E0-4B21-807C-28C7059DB829Q44764940-C3FA78ED-970E-43D7-9F78-BD29C1EFA0C3Q46860941-D05A0343-C301-47D7-A027-1A9B9406CAD9Q54491435-AEA0ED8B-4F53-4094-9DAF-774CC5EFFF86Q54571723-320D72A0-09ED-4EB4-9670-B09EDFD5EC71
P2860
Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.
@en
Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.
@nl
type
label
Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.
@en
Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.
@nl
prefLabel
Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.
@en
Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.
@nl
P2093
P2860
P356
P1476
Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.
@en
P2093
Dhawjbahadur Rawat
Hirotaka Ata
Madoka Abe
Mark S Taylor
Rakhee S Gupte
Rikuo Ochi
Sachin A Gupte
P2860
P304
P356
10.1089/ARS.2010.3207
P577
2010-10-25T00:00:00Z